Access the full text.
Sign up today, get DeepDyve free for 14 days.
O. Garin, J. Ayuso-Mateos, J. Almansa, M. Nieto, S. Chatterji, G. Vilagut, J. Alonso, A. Cieza, Olga Svetskova, H. Burger, V. Racca, C. Francescutti, E. Vieta, N. Kostanjsek, A. Raggi, M. Leonardi, M. Ferrer (2010)
Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseasesHealth and Quality of Life Outcomes, 8
James Wilson (1984)
Crime and public policyContemporary Sociology, 13
Jason Schnittker, Michael Massoglia, Christopher Uggen (2012)
Out and DownJournal of Health and Social Behavior, 53
A. Mclellan, J. McKay, Robert Forman, J. Cacciola, J. Kemp (2005)
Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring.Addiction, 100 4
A. Mehmanparast, C. Davies, K. Nikbin (2010)
Validation of the K and J Parameters in a Compact Tension Specimen Containing Intergranular and Straight Crack Paths
M. Alexander, G. Haugland, Shang Lin, D. Bertollo, Francis McCorry (2007)
Mental Health Screening in Addiction, Corrections and Social Service Settings: Validating the MMSInternational Journal of Mental Health and Addiction, 6
E. Jones (2006)
Crossing the field's quality chasm.Behavioral healthcare, 26 1
Q. Tiet, B. Mausbach (2007)
Treatments for patients with dual diagnosis: a review.Alcoholism, clinical and experimental research, 31 4
Esther Wildenberg, R. Wiers, J. Dessers, R. Janssen, E. Lambrichs, H. Smeets, G. Breukelen (2007)
A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers.Alcoholism, clinical and experimental research, 31 1
G. Andrews, Alice Kemp, M. Sunderland, M. Korff, T. Ustun (2009)
Normative Data for the 12 Item WHO Disability Assessment Schedule 2.0PLoS ONE, 4
L. Chwastiak, M. Korff (2003)
Disability in depression and back pain: evaluation of the World Health Organization Disability Assessment Schedule (WHO DAS II) in a primary care setting.Journal of clinical epidemiology, 56 6
F. Moggi, P. Ouimette, J. Finney, R. Moos (1999)
Effectiveness of treatment for substance abuse and dependence for dual diagnosis patients: a model of treatment factors associated with one-year outcomes.Journal of studies on alcohol, 60 6
S. Tiffany, L. Friedman, S. Greenfield, D. Hasin, Ron Jackson (2012)
Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders.Addiction, 107 4
P George, G Whelan, N Ait Khelifa (2007)
Quality of life and disability in alcohol and drug dependent patients undergoing treatment at Depaul HouseIeJSME, 1
D. James, Lauren Glaze (2006)
Mental Health Problems of Prison and Jail Inmates: (557002006-001)
J Schnittker, M Massoglia, C Uggen (2012)
Out and down: Incarceration and psychiatric disorderJournal of Health and Social Behaviour, 53
Christopher Lowenkamp, Edward Latessa, P. Smith (2006)
DOES CORRECTIONAL PROGRAM QUALITY REALLY MATTER? THE IMPACT OF ADHERING TO THE PRINCIPLES OF EFFECTIVE INTERVENTION*Criminology and public policy, 5
The World Health Organization Disability Assessment Scale (WHODAS) is suggested as a measure of impairment in DSM-5. The measurement of impaired functioning is crucial in the rehabilitation of dually diagnosed, addiction and mental health, patients. This study is the first to look at the use of the 12 item self report WHODAS as the primary outcome in a community correctional treatment facility for dually diagnosed patients.100 (55 male; 73 white, 25 black, 2 hispanic) former inmates, age 36.1 ± 11.1, with psychiatric and addiction diagnoses were treated in an integrated program. The 12 item WHODAS was completed by the patients during the initial evaluation and repeated an average of 11.1 ± 2.7 weeks later. The Clinical Global Impression-Severity Scale (CGI) was completed at the same time by the psychiatrist, independently of the WHODAS. At initial assessment, the CGI showed moderate severity and the WHODAS showed severe disability. CGI and WHODAS were significantly correlated (R 0.48, p < 0.0001). After three months of treatment, both measures improved: CGI with 46 % and WHODAS with 49 %. The CGI showed mild severity and the WHODAS moderate disability. The change in CGI was correlated with the change in WHODAS (R 0.57, p < 0.0001). The WHODAS appears sensitive to clinical improvement related to shortterm treatment of a highly co-morbid dual diagnosis population.
Psychiatric Quarterly – Springer Journals
Published: Sep 28, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.